期刊文献+

精制甲型肝炎灭活疫苗(YN5株)狨猴试验安全性和免疫原性 被引量:4

Immunogenicity and Safety of Purified Inactiviated Hepatitis A Vaccine(YN5 Strain)in Common Marmosets
下载PDF
导出
摘要 目的 检测精制甲型肝炎灭活疫苗的安全性和免疫原性。方法 甲型肝炎病毒YN 5株经Vero细胞培养制成精制甲型肝炎灭活疫苗。采用普通狨猴 (commonmarmoset)进行疫苗的安全性、免疫原性和保护力试验。结果 实验疫苗组和对照疫苗组狨猴均有特异抗体产生 ,对甲型肝炎病毒强毒株的攻击亦有保护作用。结论 该疫苗 (YN 5株 ) Objective To study the immunogenicity and safety of purified inactivated hepatitis A(HA) vaccine.Methods Prepare purified inactiveted HA vaccine by the culture of YN5 strain in Vero cells and test for immunogenicity and safety in common marmosets,using imported HA vaccine as control.Results Specific HA antibodies were induced in both test and control groups.The vaccine showed protective effect on the marmosets challenged with virulent HA virus strain.Conclusion The HA vaccine prepared with YN5 strain showed good safety and immunagenicity.
出处 《中国生物制品学杂志》 CAS CSCD 2004年第1期36-38,共3页 Chinese Journal of Biologicals
基金 国家高技术研究发展专项经费资助项目(2 0 0 2AA2Z3 3 13 ) 云南省科技计划资助项目(2 0 0 1XY0 1)
关键词 甲型肝炎灭活疫苗 安全性 免疫原性 狨猴 保护力 Common marmoset Inactivated HA vaccine Safety Immunogenicity
  • 相关文献

参考文献3

二级参考文献2

  • 1Mal J S,J Infect Dis,1998年,159期,621页
  • 2Mao J S,中国科学.B,1998年,31卷,338页

共引文献18

同被引文献27

  • 1万宗举,张华远,梁争论,李荣成,赵玉良,毕胜利.倍尔来福^(TM)甲乙型肝炎联合疫苗在成人中应用的安全性和免疫原性研究[J].中国计划免疫,2004,10(3):129-132. 被引量:20
  • 2练幼辉,胡彩珍,陶林,周彩莲,马波,鲁明.精制甲型肝炎灭活疫苗的狨猴保护实验[J].中国实验动物学报,2004,12(3):180-182. 被引量:4
  • 3刘令九,谢宝生,官桂范,李淑焱,薛勇,岳丹,刘景晔,王鹏富.冻干甲乙型肝炎联合疫苗组分相容性的研究[J].中国生物制品学杂志,2006,19(5):482-483. 被引量:3
  • 4Thoelen S,Van Daanne P,Leentvaer-Kuypers A,et al.The first combined vaccine against hepatitis A and B:an overiew.Vaccine,1999,17(13-14):1657-1662.
  • 5Abraham B,Baine Y,De-Clercq N,et al.Magnitude and quality of antibody response to a combination hepatitis A and hepatitis B vaccine.Antivirul Res,2002,53(1):63-73.
  • 6Nothdurft HD,Dietrich M,Zuekerman JN,et al.A new accelerated vaccination schedule for rapid protection against hepatitis A and B.Vaccine,2002,20(7-8):1157-1162.
  • 7Herck KV,Damme PV.Inactivated hepatitis A vaccine-induced antibodies:follow-up of long term persistence.J Med Virol,2001,63(1):1-7.
  • 8Thoelen S, Van Damme P, Leentvaar-Kuypers A, et al. The first combined vaccine against hepatitis A and B: an overiew [J]. Vaccine, 1999, 17 (13-14): 1657-1662.
  • 9Abraham B, Baine Y, De-Clercq N, et al.Magnitude and quality of antibody response to a combination hepatitis A and hepatitis B vaccine [J].Antiviral Res, 2002, 53 (1): 63-73.
  • 10Nothdurft H D, Dietrich M, Zuckerman J N, et al. A new accelerated vaccination schedule for rapid protection against hepatitis A and B [J]. Vaccine, 2002, 20 (7-8): 1157-1162.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部